hrs-2189
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 26, 2023 (NCT05851092)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07061210 | Phase 2 | Jul 1, 2025 | Fudan University |
| NCT06738745 | Phase 2 | Dec 31, 2024 | Fudan University |
| NCT06679036 | Phase 1/Phase 2 (Phase 2) | Nov 25, 2024 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT05851092 | Phase 1 | May 26, 2023 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fudan University | Academic/Hospital | 2 | 2 | 1 | 2024 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 2 | 2 | 2 | 2023 |
2 organizations
Page 1 / 1